Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 4 de 4
Filtrar
Más filtros











Base de datos
Intervalo de año de publicación
1.
Sci Rep ; 11(1): 22037, 2021 11 11.
Artículo en Inglés | MEDLINE | ID: mdl-34764353

RESUMEN

Conjugate vaccine platform is a promising strategy to overcome the poor immunogenicity of bacterial polysaccharide antigens in infants and children. A carrier protein in conjugate vaccines works not only as an immune stimulator to polysaccharide, but also as an immunogen; with the latter generally not considered as a measured outcome in real world. Here, we probed the potential of a conjugate vaccine platform to induce enhanced immunogenicity of a truncated rotavirus spike protein ΔVP8*. ΔVP8* was covalently conjugated to Vi capsular polysaccharide (Vi) of Salmonella Typhi to develop a bivalent vaccine, termed Vi-ΔVP8*. Our results demonstrated that the Vi-ΔVP8* vaccine can induce specific immune responses against both antigens in immunized mice. The conjugate vaccine elicits high antibody titers and functional antibodies against S. Typhi and Rotavirus (RV) when compared to immunization with a single antigen. Together, these results indicate that Vi-ΔVP8* is a potent and immunogenic vaccine candidate, thus strengthening the potential of conjugate vaccine platform with enhanced immune responses to carrier protein, including ΔVP8*.


Asunto(s)
Infecciones por Rotavirus/prevención & control , Rotavirus/inmunología , Salmonella typhi/inmunología , Fiebre Tifoidea/prevención & control , Vacunas Combinadas/inmunología , Vacunas Conjugadas/inmunología , Proteínas Virales/inmunología , Animales , Humanos , Inmunización , Ratones , Polisacáridos Bacterianos/inmunología , Polisacáridos Bacterianos/farmacología , Infecciones por Rotavirus/inmunología , Fiebre Tifoidea/inmunología , Vacunas Combinadas/farmacología , Vacunas Conjugadas/farmacología , Proteínas Virales/farmacología
2.
Vaccine ; 39(45): 6644-6652, 2021 10 29.
Artículo en Inglés | MEDLINE | ID: mdl-34642087

RESUMEN

Conjugation of carbohydrate antigens with a carrier protein is a clinically proven strategy to overcome the poor immunogenicity of bacterial polysaccharide. In addition to its primary role, which is to help generate a T cell-mediate long-lasting immune response directed against the carbohydrate antigen, the carrier protein in a glycoconjugate vaccine can also play an important role as a protective antigen. Among carrier proteins currently used in licensed conjugate vaccines, non-typeable Haemophilus influenzae protein D has been used as an antigenically active carrier protein. Our previous studies also indicate that some carrier proteins provide B cell epitopes, along with T cell helper epitopes. Herein we investigated the dual role of truncated rotavirus spike protein ΔVP8* as a carrier and a protective antigen. Capsular polysaccharide lipoarabinomannan (LAM), purified from Mycobacterium tuberculosis (M.tb), was chemically conjugated with ΔVP8*. Mouse immunization experiments showed that the resultant conjugates elicited strong and specific immune responses against the polysaccharide antigen, and the responses were comparable to those induced by Diphtheria toxoid (DT)-based conjugates. The conjugate vaccine induced enhanced antibody titers and functional antibodies against ΔVP8* when compared to immunization with the unconjugated ΔVP8*. Thus, these results indicate that ΔVP8* can be a relevant carrier protein for glycoconjugate vaccine and the glycoconjugates consisting of ΔVP8* with LAM are effective bivalent vaccine candidates against rotavirus and tuberculosis.


Asunto(s)
Vacunas contra Haemophilus , Mycobacterium tuberculosis , Rotavirus , Tuberculosis , Animales , Anticuerpos Antibacterianos , Diarrea , Ratones , Polisacáridos Bacterianos , Tuberculosis/prevención & control , Vacunas Combinadas , Vacunas Conjugadas
4.
Nat Cell Biol ; 18(9): 930-40, 2016 09.
Artículo en Inglés | MEDLINE | ID: mdl-27548913

RESUMEN

Quiescent satellite cells, known as adult muscle stem cells, possess a remarkable ability to regenerate skeletal muscle following injury throughout life. Although they mainly originate from multipotent stem/progenitor cells of the somite, the mechanism underlying the establishment of quiescent satellite cell populations is unknown. Here, we show that sex hormones induce Mind bomb 1 (Mib1) expression in myofibres at puberty, which activates Notch signalling in cycling juvenile satellite cells and causes them to be converted into adult quiescent satellite cells. Myofibres lacking Mib1 fail to send Notch signals to juvenile satellite cells, leading to impaired cell cycle exit and depletion. Our findings reveal that the hypothalamic-pituitary-gonadal axis drives Mib1 expression in the myofibre niche. Moreover, the same axis regulates the re-establishment of quiescent satellite cell populations following injury. Our data show that sex hormones establish adult quiescent satellite cell populations by regulating the myofibre niche at puberty and re-establish them during regeneration.


Asunto(s)
Diferenciación Celular/efectos de los fármacos , Proliferación Celular/efectos de los fármacos , Hormonas Esteroides Gonadales/farmacología , Fibras Musculares Esqueléticas/citología , Regeneración/fisiología , Células Madre Adultas/efectos de los fármacos , Células Madre Adultas/metabolismo , Animales , Ciclo Celular/efectos de los fármacos , Ciclo Celular/fisiología , Diferenciación Celular/fisiología , Separación Celular/métodos , Células Cultivadas , Hormonas Esteroides Gonadales/metabolismo , Ratones Transgénicos , Músculo Esquelético/citología , Regeneración/efectos de los fármacos , Ubiquitina-Proteína Ligasas/genética
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA